IC50 (functional)
|
= -4.04
|
Predicted pIC50 against Tryomastigotes Brucei rhodesiense.
|
ChEMBL.
|
12086478
|
IC50 (functional)
|
= 3.9
|
Growth inhibition of Plasmodium falciparum
|
ChEMBL.
|
19053772
|
IC50 (functional)
|
= 9.1 uM
|
Inhibition of T. gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
= 9.1 uM
|
Inhibition of T. gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
= 21.4 uM
|
Inhibitory concentration against Trypanosoma cruzi (amastigotes)
|
ChEMBL.
|
12951099
|
IC50 (functional)
|
= 21.4 uM
|
In vitro antiparasitic activity against T. cruzi (amastigotes)
|
ChEMBL.
|
11277521
|
IC50 (functional)
|
= 21.4 uM
|
Inhibitory concentration against Trypanosoma cruzi (amastigotes)
|
ChEMBL.
|
12951099
|
IC50 (functional)
|
= 21.4 uM
|
In vitro antiparasitic activity against T. cruzi (amastigotes)
|
ChEMBL.
|
11277521
|
IC50 (binding)
|
= 21.5 uM
|
Inhibition of recombinant trypanosoma brucei soluble vacuolar pyrophosphatase expressed in escherichia coli
|
ChEMBL.
|
16162013
|
IC50 (binding)
|
= 21.5 uM
|
Inhibition of recombinant trypanosoma brucei soluble vacuolar pyrophosphatase expressed in escherichia coli
|
ChEMBL.
|
16162013
|
IC50 (binding)
|
= 42.83 uM
|
Inhibition of Trypanosoma cruzi farnesyl pyrophosphate synthase
|
ChEMBL.
|
12951099
|
IC50 (binding)
|
= 42.83 uM
|
Inhibition of Trypanosoma cruzi farnesyl pyrophosphate synthase
|
ChEMBL.
|
12951099
|
IC50 (functional)
|
> 70 uM
|
Inhibitory concentration against Trypanosoma cruzi (epimastigotes)
|
ChEMBL.
|
12951099
|
IC50 (functional)
|
> 70 uM
|
In vitro antiparasitic activity against T. cruzi (epimastigotes)
|
ChEMBL.
|
11277521
|
IC50 (functional)
|
> 70 uM
|
Inhibitory concentration against Trypanosoma cruzi (epimastigotes)
|
ChEMBL.
|
12951099
|
IC50 (functional)
|
> 70 uM
|
In vitro antiparasitic activity against T. cruzi (epimastigotes)
|
ChEMBL.
|
11277521
|
IC50 (functional)
|
= 92 uM
|
In vitro growth inhibition of blood-stream-form Trypanosoma brucei rhodesiense Trypomastigotes
|
ChEMBL.
|
12086478
|
IC50 (functional)
|
= 92 uM
|
Inhibition of T. rhodesiense (strain STIB900) was determined using blood stream from trypomastigotes
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
= 92 uM
|
Inhibition of T. rhodesiense (strain STIB900) was determined using blood stream from trypomastigotes
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
= 92 uM
|
In vitro growth inhibition of blood-stream-form Trypanosoma brucei rhodesiense Trypomastigotes
|
ChEMBL.
|
12086478
|
IC50 (binding)
|
> 100 uM
|
Inhibitory concentration of the compound against Trypanosoma brucei farnesyl pyrophosphate synthase activity
|
ChEMBL.
|
12951099
|
IC50 (binding)
|
> 100 uM
|
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase
|
ChEMBL.
|
14695831
|
IC50 (binding)
|
> 100 uM
|
Inhibitory concentration of the compound against Trypanosoma brucei farnesyl pyrophosphate synthase activity
|
ChEMBL.
|
12951099
|
IC50 (binding)
|
> 100 uM
|
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 130 uM
|
Inhibition of P. falciparum (intraerythrocytic stages) strain 3D7
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
= 130 uM
|
In vitro growth inhibition against Plasmodium falciparum
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 130 uM
|
Inhibition of P. falciparum (intraerythrocytic stages) strain 3D7
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
= 130 uM
|
In vitro growth inhibition against Plasmodium falciparum
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 130 uM
|
Growth inhibition of Plasmodium falciparum
|
ChEMBL.
|
19053772
|
IC50 (functional)
|
= 130 uM
|
Antimicrobial activity against Plasmodium falciparum
|
ChEMBL.
|
20185316
|
IC50 (functional)
|
> 200 uM
|
Inhibition of T. cruzi Amastigotes was determined in Vero cells culture and fetal calf serum
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
> 200 uM
|
Inhibition of L. donovani(Amastigotes) strain MHOM/ET/67/L82 maintained in female golden hamsters
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
> 200 uM
|
In vitro growth inhibition against Entamoeba histolytica
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
> 200 uM
|
Inhibition of T. cruzi Amastigotes was determined in Vero cells culture and fetal calf serum
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
> 200 uM
|
Inhibition of L. donovani(Amastigotes) strain MHOM/ET/67/L82 maintained in female golden hamsters
|
ChEMBL.
|
11300872
|
IC50 (functional)
|
> 200 uM
|
In vitro growth inhibition against Entamoeba histolytica
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 200 uM
|
Antimicrobial activity against Entamoeba histolytica
|
ChEMBL.
|
20185316
|
IC50 (binding)
|
= 620 uM
|
Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase).
|
ChEMBL.
|
12014956
|
IC50 (binding)
|
= 620 uM
|
Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase).
|
ChEMBL.
|
12014956
|
IZ (functional)
|
= 0 mm
|
Antibacterial activity against Escherichia coli W3110
|
ChEMBL.
|
17149863
|
IZ (functional)
|
= 0 mm
|
Antibacterial activity against Escherichia coli W3110
|
ChEMBL.
|
17149863
|
Ki (binding)
|
= 5.04 uM
|
Binding affinity of the compound towards T. cruzi farnesyl pyrophosphate synthase (TcFPPS)
|
ChEMBL.
|
12951099
|
Ki (binding)
|
= 5.04 uM
|
Binding affinity of the compound towards T. cruzi farnesyl pyrophosphate synthase (TcFPPS)
|
ChEMBL.
|
12951099
|
LD50 (ADMET)
|
> 967 uM
|
50% lethal dose for inhibition of KB cells growth
|
ChEMBL.
|
12086478
|
LD50 (ADMET)
|
> 967 uM
|
Toxicity evaluated against human nasopharyngeal carcinoma KB cell line
|
ChEMBL.
|
14695831
|
LD50 (ADMET)
|
> 967 uM
|
50% lethal dose for inhibition of KB cells growth
|
ChEMBL.
|
12086478
|
LD50 (ADMET)
|
> 967 uM
|
Toxicity evaluated against human nasopharyngeal carcinoma KB cell line
|
ChEMBL.
|
14695831
|
Log IC50 (functional)
|
= 4.04
|
Predicted pIC50 against Tryomastigotes Brucei rhodesiense.
|
ChEMBL.
|
12086478
|
TI (ADMET)
|
> 7.44
|
Therapeutic index was expressed as ratio of LD50 for KB cell line to IC50 against Plasmodium falciparum
|
ChEMBL.
|
14695831
|
TI (ADMET)
|
> 11
|
Therapeutic index measured as the ratio of LD50 (KB cells) to IC50 (T.b. rhodesiense)
|
ChEMBL.
|
12086478
|